Provided by Tiger Fintech (Singapore) Pte. Ltd.

Orchestra BioMed

4.08
+0.24006.25%
Post-market: 4.080.00000.00%16:23 EDT
Volume:43.60K
Turnover:175.43K
Market Cap:155.10M
PE:-2.55
High:4.13
Open:3.93
Low:3.88
Close:3.84
Loading ...

Orchestra BioMed Holdings Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow Jones
·
10 Mar

Orchestra BioMed Highlights Strategic Initiatives and Innovations

TIPRANKS
·
03 Mar

Orchestra BioMed Updates Executive Compensation Policies

TIPRANKS
·
26 Feb

Orchestra names Vivek Reddy as chairman of BACKBEAT study steering committee

TIPRANKS
·
18 Feb

Orchestra Biomed Appoints Vivek Reddy, M.d. as Executive Chairman of the Backbeat Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

THOMSON REUTERS
·
18 Feb

Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive Chairman of the BACKBEAT Study Steering Committee and Chairman of Bioelectronic Therapies Scientific Advisory Board

GlobeNewswire
·
18 Feb

Orchestra BioMed Says AVIM Therapy Improves Echo Markers of Diastolic Dysfunction

MT Newswires Live
·
13 Feb

Orchestra BioMed announces data on atrioventricular interval modulation therapy

TIPRANKS
·
12 Feb

Orchestra Biomed Announces Data Demonstrating Favorable Impact of Avim Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, Will Be Presented as Late-Breaking Science at the Tht 2025 Conference

THOMSON REUTERS
·
12 Feb

Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference

GlobeNewswire
·
12 Feb

Orchestra BioMed Appoints New Director Amid Board Changes

TIPRANKS
·
05 Feb

Orchestra BioMed announces appointment of Cleary to board of directors

TIPRANKS
·
05 Feb

Orchestra Biomed Announces Appointment of Former Medtronic Svp of Corporate Development Christopher Cleary to Board of Directors

THOMSON REUTERS
·
05 Feb

Press Release: Orchestra BioMed Announces Appointment of Former Medtronic SVP of Corporate Development Christopher Cleary to Board of Directors

Dow Jones
·
05 Feb

US Penny Stocks Spotlight: AC Immune And Two Others To Consider

Simply Wall St.
·
03 Jan

Orchestra BioMed Up 49% After Barclays Starts Coverage With $16 Target

Dow Jones
·
03 Jan